Swiss crypto asset manager 21Shares predicts Bitcoin will recover to $100,000-$110,000 by the end of 2026, viewing the current 50% price drop as a consolidation phase rather than a collapse. Key factors supporting this outlook include increased accumulation by long-term holders, a rising stablecoin supply indicating investor readiness to buy, and a strong support level around $60,000 aligned with Bitcoin's 200-week moving average. The firm also notes that a break above $70,000 could trigger a short squeeze, accelerating gains. However, risks remain from ETF outflows and geopolitical tensions that initially caused the sell-off. Investors should watch ETF flow data as a key indicator of market sentiment.
Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...
Qualys reported strong Q2 2026 results, with earnings per share of $1.98 surpassing the $1.78 consensus and revenue of $182.2 million, an 11% year-over-year increase. The company raised its full-year 2026 revenue guidance to $732-$738 million, reflec...
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...
Pomerantz LLP is investigating Karyopharm Therapeutics for potential securities fraud related to a retention program granting top executives lump sum cash bonuses between $625,000 and $1,725,000. The announcement led to a 21.45% drop in Karyopharm's ...
LiveOne announced it will release its first quarter fiscal 2027 financial results on August 12, 2026, with a conference call to discuss the performance. The company expects continued year-over-year growth in revenue and adjusted EBITDA, driven by org...
